Vysis Inc. acquired by Abbott Laboratories
|
|
|
|
|
leading Genomic Disease Management company that develops. commercializes and markets clinical products providing information critical to the evaluation and management of cancer. prenatal disorders and other genetic diseases | |
Korean Distributor : ¾Öº¸Æ®ÄÚ¸®¾Æ (Abbott Korea Co. Ltd.) |
Products information :
|
|
|
|
|
|
|
|
|
|